A large number of local medical insurance adjustments began

▍ recently, Tianjin Medical Insurance Bureau issued the notice of the Municipal People's and Social Security Bureau of the Municipal Medical Insurance Bureau on docking the national drug catalog in 2019 According to the notice, the docking scope of this medical insurance catalog in Tianjin is: 1 For the western medicine, Chinese patent medicine and negotiated medicine catalog in the national drug catalog, and the drugs and their classification, remarks (limited payment scope) and other information in line with the requirements of the national drug catalog "general rules", the docking scope shall be listed in strict accordance with the national regulations; 2 The non-national drugs listed in the current drug catalog of our city are included in the docking scope, and the category and remarks (limited payment scope) are not adjusted The state key monitoring drugs and the drugs deleted in the process of national drug catalog adjustment are not included in the docking scope; 3 Chinese herbal pieces and hospital preparations of medical institutions shall be separately organized for docking according to the requirements of national documents and the work arrangement of our city From the above requirements, it can be found that at present, Tianjin has eliminated the national key monitoring drugs and the varieties transferred out of the national health insurance catalog in the current round of national health insurance catalog adjustment Although there is no mention of clearing up the original local supplementary varieties of medical insurance, I believe it will be sooner or later under the requirements of national policies According to the regulations, the following varieties will no longer be included in the reimbursement scope of Tianjin Medical Insurance: national key monitoring drugs (20 varieties): 2019 national medical insurance catalog transfer out varieties: (data source: medicine magic cube) ▍ 30 varieties Recently, the medical insurance catalog of Guangdong Province 2019 version has been circulated in the industry It is reported that the catalogue is divided into six parts: general medicine, western medicine, Chinese patent medicine, national negotiated drugs during the agreement period, Chinese herbal pieces and hospital preparations Among them, 2934 are western medicine and Chinese patent medicine, of which 1425 are western medicine, 1461 are Chinese patent medicine (including 97 ethnic medicine), and 48 are negotiated during the agreement period (including 43 western medicine and 5 Chinese patent medicine) According to the statistics of Fengyun pharmaceutical, 30 varieties were removed from the previous version of the catalogue according to the circulated documents The details are as follows: (data source: Fengyun pharmaceutical Statistics) according to the information previously confirmed by cypress blue from authoritative channels, the local government added the varieties in the medical insurance catalogue and required to transfer out the catalogue in batches within 3 years The arrangements for transfer out are as follows: 1 The drugs in the key monitoring catalogue are first removed from the medical insurance catalogue; 2 In principle, the supplementary varieties in other places will be cleaned up within three years, with the proportion of varieties cleaned up in three years being 40%, 40% and 20%, respectively From the current provinces and cities that have carried out the adjustment of the medical insurance catalog, the first point is basically achieved I believe that from next year, all regions will successively start to add varieties to the local market That is to say, at the latest in 2022, the local medical insurance catalogue will become history Those varieties that were once supplemented by local governments but failed to squeeze into the national medical insurance catalogue will lose the "halo" of medical insurance, which is a great challenge to maintain their market share ▍ what about medical representatives? Due to the strong regional characteristics of medical representatives, local medical insurance supplement is very important for many medical representatives With the start of "operation" of medical insurance supplement, it is believed that it will bring great pressure to many medical representatives In recent years, the two ticket system, the proportion of controlled drugs, and the national volume procurement Under a series of policy combinations, the circulation link is gradually compressed Once the so-called intermediate link is completely cut down, the business model of most medical representatives in the past has lost its existence space It is understood that the sales expenses of pharmaceutical enterprises usually account for a large part However, after the state purchases drugs with volume, due to the sharp drop in drug prices, the enterprises will cut down the original high sales expenses Moreover, the national procurement with quantity is to define the variety and quantity, and pharmaceutical enterprises will no longer need to hire a sales team to promote their products.